Ocular Implant Market in Asia Pacific Witnesses Significant Growth, Due to High Prevalence of Cataract and Cataract Blindness in China

 

The worldwide ocular implant market is divided into corneal implants, middle and extruded lenses, and bifocal lenses. Each category features different functionalities, thus increasing the chances for finding a matching eye implant for the patient's requirements. The demand for these in the market has grown tremendously due to its promising effects and favorable outcomes. This is the reason that it has been ranked as one of the top choices of patients who are suffering from eye defects. Some of the common types of ocular implants in the market include:

Corneal Implants: A cornea transplant is a surgical procedure to replace part of your cornea with corneal tissue from a donor. With increasing number of advancements in technology, the surgical procedure is being made easier and safer for the patients. According to the latest statistical data, the demand for ocular implants has been increasing steadily in the world as per the latest surveys. The global ocular implant market can be broadly classified into five sectors - intraocular lenses (IOL), eye surgery lenses (GL), bifocal lenses (BFL), and laser eye surgery glasses. Moreover, there is an increasing number of manufacturers in this field.

Bifocal Devices: The bifocal eye glasses have gained popularity worldwide with its ability to provide clear vision and the fastest-growing segment within ocular implant market. However, with growing age, people face problems like dry eyes, prescribed reading glasses and other visual problems. Hence, today the market is flooded with replacement eyeglasses, including progressive and bifocal eye glasses. These glasses can be replaced by various brands such as progressive eye glasses, bifocal reading glasses, and IOLs.

The global ocular implant market is currently undergoing tremendous advancements, with high prevalence of ocular diseases. According to The International Agency for the Prevention of Blindness, 80 million people are expected to suffer from glaucoma by 2020 compared to 20 million since 2010. Moreover, according to the study, ‘The national and subnational prevalence of cataract and cataract blindness in China: a systematic review and meta-analysis’, published in the Journal of Global Health in June 2018, the prevalence of any cataract ranged from 6.71% in people aged 45-49 years to 73.01% in elderly aged 85-89 years in males. This in turn is expected to aid in growth of the ocular implant market in Asia Pacific.

Ability of Companies in Citrus Flavors Market to Ride out the Storm is Increasingly Difficult with the Current Pandemic Affecting All Sectors of Economy Worldwide

 

The primary purpose of Coherent Market Insights’ global citrus flavors market report is to offer insights about opportunities in the international market which are supportive of the transformation of international industries related to citrus flavors. With the current pandemic affecting all sectors of the economy worldwide, the ability of companies in the citrus flavors market to ride out the storm is increasingly difficult. However, the rising popularity of imported juices, salsas, tamarinds, and a host of other processed and prepared beverages from across the world, together with the resultant increase in consumption of more processed foods and food ingredients, has resulted in increased competition among the manufacturers of these products. In order to succeed in this market segment, it is essential to carefully analyze and decipher the complexities of this segment's economics.

One of the most important factors influencing the segment's competitive advantage is its ability to leverage on rising demand in developed citrus flavors markets while maintaining competitive advantage in emerging markets. Companies in this segment have a unique opportunity to expand their market share in developed countries, while at the same time increasing market share in less-developed countries through the adoption of innovative manufacturing strategies. This combination allows manufacturers of citrus flavors to gain market share not only in the U.S. but also in Canada, Japan, China and Europe. Additionally, rising demand in these markets provides a significant opportunity for manufacturers to gain ground in developing countries such as Brazil, India and Mexico. The ability of manufacturers of citrus flavors to tap into the rising demand in lesser-developed markets will prove to be an essential factor supporting their ability to maintain market leadership over other competing manufacturers.

To successfully capitalize on the growing global citrus flavors market potential, manufacturers must develop advanced quality production systems that provide consistent quality throughout the supply chain. This includes thorough quality control at all phases of production including sourcing, transportation, through the sale and final disposal of finished products. By reducing waste and excessive packaging, companies can further reduce their overall manufacturing cost. Additionally, by streamlining distribution channels and developing improved warehouse logistics, these companies can improve the accuracy and speed of distribution, thereby enhancing the impact of their marketing communications. Likewise, by streamlining distribution, companies can better assure consumers of consistent delivery of their products in a timely manner.

One of the factors influencing the segment's competitive advantage is its ability to create and deliver consistent flavors that consistently draw customers in through strong brand recall and powerful advertising campaigns. Several studies have shown that consumer perceptions of citrus fruits consistently vary depending on the type of fruit they are exposed to. Consumers can easily change their minds about a product after consuming it, thereby increasing the chances of generating new sales opportunities through recall and brand exposure. Additionally, increasing popularity and increasing taste sensitivity of citrus flavors can also increase citrus flavors market share.

Another important factor for the increasing popularity of citrus flavors is the industry's recognition of its health benefits. Through rigorous studies and independent clinical research, health experts have determined that the naturally occurring citrus oils are beneficial in preventing chronic diseases and maintaining optimal health. Citrus is considered to be one of nature's richest sources of vitamin C, which has proven to be an effective treatment against tooth decay. Moreover, citrus juices are known to improve the digestion process and inhibit gastric acid production. These benefits have encouraged consumers to purchase citrus flavors in increasing numbers.

Bulletproof glass market is witnessing strong growth in North America region

 

Growth in the automotive industry around the globe and growing demand for a luxury vehicle is primarily augmenting the growth of the bulletproof glass market. According to the European Automobile Manufacturers Association, around 98.1 million motor vehicles were produced around the world in 2018 and more than 80 million passenger cars were produced around the world in 2017. Hence rising production of automobiles around the world is projected to propel the market growth of bullet-proof security glass. Moreover, expanding the financial sector around the globe is another key factor expected to accelerate the growth of the bulletproof glass market. This sector is a highly prone area for terror attacks and robbery and thus bulletproof glass is necessary for protection. According to the International Trade Administration, by the end of 2018, the U.S. banking system had $17.9 trillion in assets and a net income of $236.8 billion.

Asahi Glass Co., Ltd, China Specialty Glass AG, Nippon Sheet Glass Co. Ltd., Saint-Gobain S.A., China Glass Holdings Ltd., PPG Industries, Inc., Taiwan Glass Ind. Corp., Apogee Enterprises, Inc., Şişecam, and Guardian Industries Corp are major key players in the market

North America is expected to dominate the global bulletproof glass market and this is accredited to the growing installation of bulletproof glass by a big organization to improve the safety of the worker in the region. For instance, in December 2018, Pacific Gas & Electric Co. has installed bullet-proof glass at its customer service center in Redding for enhancing the safety of the customers and employees.

In August 2018, Mercedes-Benz launched the 2018 INKAS Mercedes-Benz G63 AMG is a stunning bullet-proof armored SUV limousine at a price of one million euros

Bulletproof glass, bulletproof armor, bulletproof glass, bullet-resistant fiberglass, or bulletproof steel is an ultra-violet resistant, ultra-plastic material that is especially strong and optically clear. Although the material is extremely effective in deterring penetration of objects and minimizing damage from injuries, it isn't impermeable on its own. This is where the special properties of this type of glass come into play.

Due to its properties, bulletproof glass has three layers. The outermost layer is made of plastic polymers with various levels of toughness, often up to 300% more durable than normal plastic polymers. The middle layer is composed of various plastics, including high-tempered polyvinyl chloride (HTP), epoxy resin, and other resins. Finally, the innermost layer is composed primarily of glass fibers, which are infused with a specially designed oxidizing agent to create the desired optical properties.

Gilead Sciences, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted approval of Trodelvy for bladder cancer therapeutics market

 

According to the study of the American Society of Clinical Oncology (ASCO), urothelial carcinoma accounts for around 90%, squamous cell carcinoma accounts for 4%, and adenocarcinoma accounts for 2% of all bladder cancer. The remaining 4% of bladder cancer includes other rare types of bladder cancer viz. sarcoma and small cell anaplastic cancer. Thus, the bladder cancer therapeutics market is experiencing strong growth on the account of the growing prevalence of bladder cancer. As per stats released by the International Agency for Research on Cancer (IARC), 59% of bladder cancer cases are observed in developed countries, with Belgium reporting the highest number of bladder cancer cases. Moreover, continuous advancements in clinical research have resulted in the development of new and advanced therapies for bladder cancer which is further projected to augment the growth of the market.

In April 2021, Gilead Sciences, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted approval of Trodelvy® (sacituzumab govitecan-hziy) for use in adult patients with locally advanced or metastatic urothelial cancer (UC) who have previously received a platinum-containing chemotherapy and either a programmed death receptor-1 (PD-1)

In April 2018, Roche announced that Tecentriq has been approved in India for two types of cancersnon-small cell lung cancer (NSCLC) and urothelial carcinoma, a type of bladder and urinary tract cancer

In June 2020, EMD Serono, the biopharmaceutical business of Merck KGaA and Pfizer Inc. announced that the US Food and Drug Administration (FDA) has approved the supplemental Biologics License Application (sBLA) for BAVENCIO® (avelumab) for the maintenance treatment of patients with locally advanced or metastatic urothelial carcinoma (UC) that has not progressed with first-line platinum-containing chemotherapy.

North America is projected to witness strong growth in the global bladder cancer therapeutics market owing to increasing FDA approval for the launch of new and advanced bladder cancer therapies. For instance, in December 2019, the U.S. Food and Drug Administration granted accelerated approval to Padcev (enfortumab vedotin-ejfv), a Nectin-4-directed antibody and microtubule inhibitor conjugate, meaning the drug specifically targets cancer cells – in this case, the cell adhesion molecule Nectin-4, which is highly expressed in urothelial cancers.

Bladder cancer occurs when normal bladder tissue grows abnormally and invades other organs. Bladder cancer can be either primary or secondary. The first stage of bladder cancer occurs on the outside of the bladder, while the second stage occurs on the inside of the bladder. Bladder cancer therapeutics includes bladder liquid laser ablation, cryosurgery, perineal laser ablation, radical prostatectomy, perianal laser ablation, proton beam radiation therapy, selective laser radiotherapy, transrectal ultrasound therapy, transurethral resection, and transurethral resection. Staging is done according to the incidence and function of the disease.

Bulletproof Vests Are Among the Most High-Demand Items in Ballistic Composites Market

 

Ballistic composites market report by Coherent Market Insights addresses an in-depth examination of the following segments of the ballistic technologies: by application-vehicle armor (marine vehicle armor, land vehicle armor, and air vehicle armor), by type (ballistic body armor, and helmets and protective underwear), along with regional segmentation. As a strategic deterrent to terrorists, this technology can also be employed to protect troops. This is a high impact armor solution providing superior protection to our personnel and critical missions.

Industry Overview: The report tracks the growth of the ballistic composites market, discussing key drivers, trends, and potential areas for growth. It then presents the key business segments and provides the overall outlook for the industry. The applications category examines various applications type of this product, which may include modular armor systems, tactical vests, modular helmets, bullet resistant body armors, as well as protective face wear. The vehicle category discusses types of ballistic body armor to include armor piercing, and bullet proof. The segment focuses on bullet resistant and hard-ware jackets. Finally, the face protection category looks at bullet-proof vests for law enforcement, fire fighter, and soldiers.

Ballistic Vehicle Armor: This technology in the ballistic composites market can be used to replace many layers of armor on an armored vehicle. By improving the hardness of a conventional vest or bulletproof vest, this can effectively reduce the weight and increase the effective defense of your vests. In addition, it provides many years of service life and superior shock absorption. By improving upon the performance of conventional vests and bulletproof vests this technology has been made available in the marketplace.

Bulletproof vests are among the most high-demand items in the ballistic composites market. Many believe this is one of the best ways to protect those who serve in armed forces and in police departments. With many of our troops risking their lives while serving overseas and at the same time police officers risk their lives in line with protecting the public, bulletproof vest programs are of high demand. In fact, many cities around the nation are installing bulletproof vest programs within their police departments.

Other ballistic composites in the ballistic composites market have shown to be effective against many different types of crime. Common examples include stopping robbers with steel breaking through steel doors and windows, and also preventing harm from a variety of dangerous substances, such as ricin. Additionally, they are used in various law enforcement and military agencies as well as to protect senior citizens and those with disabilities. In the military bulletproof vests are considered one of the highest standards of protection for those serving in our armed forces overseas.

Weight Loss and Weight Management Market is gaining robust traction with Novo Nordisk receiving the U.S. FDA approval for Wegovy injection for chronic weight management in adults with obesity or overweight

 

Weight management is the term used to describe the various biological processes and psychological ways which lead to an individual's ability to achieve and maintain a particular weight. Many weight management practices involve daily physical activity and long-term dieting, which promote healthy eating among individuals who are obese. As far as geographical impact is concerned, North America seems to be gaining significant traction in the weight loss and weight management market. This is due to high disposable income and the presence of a massive patient pool across the U.S. Besides, growing awareness among the populace and a rise in the incidence of health disorders could further accelerate the regional market growth. On the contrary, Asia Pacific seems to be exhibiting lucrative signs with an increase in fitness consciousness among people in India and China.

One of the most obvious reasons for the high adoption of weight management is rising burden of obesity and relevant chronic diseases. As per the World Health Organization (WHO), in 2016, over 1.9 billion adults aged 18 years and above were overweight, of which around 650 million were obese. As per the same source, in 2016, around 340 million children and adolescents aged 5-19 years were overweight or obese. This, in turn, can augment growth of the weight loss and weight management market.

Weight management experts consider several factors that should be taken into consideration when designing a weight management program. Factors such as lifestyle, age, and genetic predisposition are the main focus of this treatment and should not be ignored. Some health professionals recommend weight loss programs based on a particular genetic predisposition. Despite these factors, there are certain challenges that remain prevalent and can hinder market growth. For instance, high costs associated with low-calorie diets and deceptive marketing practices can impede growth of the weight loss and weight management market. Besides, stringent regulations on product approval can further restrict market growth.

Apart from high obesity rate, there are several other reasons for high adoption of weight loss programs. For instance, growing prevalence of lifestyle diseases such as hypertension, stress, and diabetes has increased the adoption of weight loss programs. As per the WHO, in 2021, around 1.13 billion people worldwide were living with hypertension, with the majority of the population from emerging economies. Therefore, such factors can stimulate growth of the weight loss and weight management market in the near future. Recently, in June 2021, Novo Nordisk received the U.S. Food and Drug Administration (FDA) approval for Wegovy injection for chronic weight management in adults with obesity or overweight.

Waterproofing admixture market is experiencing as MC-Bauchemie launch new crystalline waterproofing of concrete

 

Growing demand for waterproof products from the construction industry is predominantly propelling the growth of the waterproofing admixture market. So rise in the construction industry especially in the Asia Pacific region is augmenting the growth of the market. According to the India Brand Equity Foundation, India is expected to become the third-largest construction market globally by 2022. India plans to spend US$ 1.4 trillion on infrastructure projects through the National Infrastructure Pipeline (NIP), from 2019 to 2023, to ensure sustainable development in the country. The increasing focus of key players to adopt various growth strategies is again accelerating the growth of the waterproofing admixture market. For instance, in October 2018, Chryso acquired Chemtec Admixtures Ltd. to expand its admixture business in Ireland.

In April 2021, MC-Bauchemie launches new product line for the crystalline waterproofing of concrete. Centrament Proof C is a new range consisting of the two admixtures Centrament Proof CL 1 and Centrament Proof CP 10, both formulated for the waterproofing of concrete through crystallization

In April 2020, Sika announced the launch of two core product technologies in permeability reducing admixtures - hydrophilic crystalline and hydrophobic pore blocking

The Asia Pacific is expected to hold a dominant position in the global waterproofing admixture market owing to the rapid urbanization in the region. According to the United Nation, Asia-Pacific is now dominantly urban — more than half the region’s population in 2019 live in cities and towns. The region’s urban population exceeded 2.3 billion, comprising 54 percent of all urbanites on the planet. The region’s number of urban dwellers is expected to rise to more than 2.8 billion in 2030 and reach nearly 3.5 billion in 2050.

A waterproofing admixture is a mixture of resins, concrete mix, and grouts that are used in order to create a substance that is impervious to moisture, chemicals, fuels, saltwater, biodegradable liquids, fungi, bacteria, and other contaminants that can cause damage to concrete structures. These materials can also help prevent the growth of mold or other biological hazards that can be detrimental to the health and safety of employees and the public. Waterproofing can be an expensive endeavor, however, so it is important that these issues are addressed as soon as possible. In this article, we will discuss how the right waterproofing admixture can save a business or organization thousands of dollars per year.

Venipuncture Needle and Syringes Market Driven By Increasing Diagnostic-Screening of Many Diseases That Require Blood Test

 

In medical science, venipuncture is basically the procedure of receiving intravenous access to the forearm to obtain venous blood sample or venipuncture. It is done by inserting a needle into the skin of the affected part and drawing out blood through the force of a strong stream of blood. The collected blood is then placed in a disposable syringe and can be used for various tests and purposes like culture of microorganisms, examination of anatomy, blood grouping, and so on. Sometimes, too, the needle may puncture through the skin resulting in some loss of blood. In such cases, the blood is frozen at low temperature and sent for testing.

This can be done with the use of venipuncture needle and syringes and with an increased number of blood tests and blood collections. Therefore, there is a proportional increase in the venipuncture needle and syringes market. Venipuncture is the process of obtaining intravenous access for the purpose of venous blood sampling or intravenous therapy. 21-gauge needles are commonly used for venipuncture, whereas 16-gauge needles are commonly used for the blood donation. Venipuncture with a syringe requires the nurse to exert aspiration pressure against the syringe plunger. This method involves inserting a hollow-bore needle attached to a syringe into the lumen of a large vein to obtain a specimen.

Another major factor responsible for the venipuncture needle and syringes market growth is the increasing number of diagnostics and screening tests for diseases, such as leukemia and anemia, which involves the collection of blood. Thus, with the increasing prevalence of anemia and leukemia, the demand for venipuncture needle and syringes is also increasing. Leukemia is 15th most commonly diagnosed cancer and 11th leading cause of cancer death worldwide. According to the Leukemia & Lymphoma Society (LLS), in 2020, a total of 178,520 people in the United States were expected to be diagnosed with leukemia, lymphoma, or myeloma.

This in turn is expected to augment the growth of the venipuncture needle and syringes market in the U.S. Moreover, increasing awareness of blood donation and the growing preference for disposable products for blood drawing are a few other factors accelerating the market growth. Venipuncture is the oldest invasive procedures, carried out for five basic reasons, such as to identify the levels of blood components, to collect blood for investigative purposes, to eliminate blood due high presence of iron or erythrocyte, administer chemotherapy, nutrition, or drugs, and to collect blood which might be useful later in transfusion purpose.

Thus, there is an increasing demand for venipuncture around the world, driving the growth of the venipuncture needle and syringes market.

Vagus Nerve Stimulators Market is developing rapidly with electroCore Inc. receiving the U.S. Food and Drug Administration (FDA) 510(k) clearance for its gammaCore, a vagus nerve stimulator

 

Vagus nerve Stimulators are electronic devices that are placed inside the abdominal area. The idea behind it is that when placed near the spleen there will be relief of symptoms associated with Vagus Nerve compression, which includes pain, spasms, vomiting, and nausea. The primary factor that could aid growth of the market is rapidly growing cases of neurological and cardiovascular disorders. As per the World Health Organization (WHO), around 17.9 million people die of cardiovascular diseases every year. As per the Alzheimer Association, in 2021, around 6.2 million people in the U.S. aged 65 years and above are living with Alzheimer’s dementia. This, in turn, has led to rapid demand for vagus nerve stimulators, which helps to improve heart rate variability with better vagal reflexes. Hence, such factors can stimulate growth of the vagus nerve stimulators market.

As far as geographical impact is concerned, North America is exhibiting a positive outlook in the vagus nerve stimulators market since there is the presence of modern healthcare systems and technological advancements in healthcare practices. On the contrary, Asia Pacific seems to be gaining robust traction due to high incidence of neurological disorders in the region. Recently, in February 2021, electroCore Inc. received the U.S. Food and Drug Administration (FDA) 510(k) clearance for its gammaCore, a vagus nerve stimulator for preventive treatment of adolescent migraine.

Vagus Nerve Stimulators are a specific category of therapeutic devices that are used in the treatment of diseases and conditions that affect the functioning of the brain. While their main function is to relieve pain associated with Vagus Nerve Compression, they can also help with refractory spasticity associated with some brain injuries. Despite these accelerating factors, certain challenges can still impede market growth. For instance, high cost associated with these devices can limit growth of the vagus nerve stimulators market. Besides, the lack of reimbursement policies in emerging economies can potentially restrict market growth in the near future.

Vagus Nerve Stimulators are a relatively new therapeutic device that has shown promising results in the treatment of depression, especially in patients who are unresponsive to other medications. It has been found that using Vagus Nerve Stimulators effectively treats depression when combined with counseling and behavior modification techniques. Elderly people, typically aged 60 years and above are most vulnerable to cardiovascular and neurological disorders. With the rapidly increasing geriatric population, the demand for vagus nerve stimulators is likely to surge. According to the WHO, by 2050, the global population aged 65 years and above is expected to reach around 2 billion increasing from 900 million in 2015. Hence, such factors can augment growth of the vagus nerve stimulators market.

Small Molecule Cancer Drugs Market is gaining major traction due to Genesis Therapeutics collaborating with Genentech for AI-driven multi-target drug discovery

 

Small molecule cancer drugs is in the very early stages of development for use in the treatment of cancer. In recent years, it has been found that cancer cells secrete chemicals as a defense against cancer treatments. These chemicals can be detected by the body's immune system, and these chemicals are often found within tumors. The body's immune system recognizes some cancer cells as foreign particles that may be harmful to the body. With growing cancer burden worldwide, key pharmaceutical and biotechnology companies are focused on developing novel therapies and medications for the treatment of different types of cancer. With growing focus on small molecule cancer drugs, research and development activities are likely to surge in the near future. Hence, such factors can augment growth small molecule cancer drugs market in the near future. Recently, in November 2020, Genesis Therapeutics collaborated with Genentech for AI-driven multi-target drug discovery.

One of the most obvious factors aiding growth of the said market is the rapidly increasing incidence of cancer across the globe. As per the World Health Organization (WHO), in 2018, around 9.6 million deaths were reported due to cancer globally, of which 2.09 million cases were due to lung cancer. As per the same source, in 2018, around 9.6 million deaths were reported due to cancer globally, of which 2.09 million cases were due to lung cancer. Small molecule cancer drugs have been found successful in treating cancer as they can affect molecules such as a protein that may cause cancer. Hence, such factors can stimulate growth of the small molecule cancer drugs market.

Regardless of the advantageous factors, challenges such as high drug development costs can impede growth of the small molecule cancer drugs market. Drug development requires a significant amount of investment and thus limited number of companies are focused on small molecule cancer drugs R&D. Besides, the stringent regulatory frameworks can further inhibit growth of the market in the near future.

Small molecule inhibitory antibodies (S MIAs) are a new class of anti-cancer drugs that have high promise as effective anticancer agents. An SMIA is a protein complex that recognizes specific cancer cells. Once the SMIA recognizes the cancer cell, it triggers a biological response that destroys cancer. When it comes to geographical impact, North America seems to be gaining significant traction in the small molecule cancer drugs market. This is due to large incidences of cancer across the U.S. On the contrary, Asia Pacific is showing promising signs due to improving healthcare infrastructure in India and China.

Europe is expected to hold a dominant position in the global plastic pallets market owing to growing adoption of plastic pallets in the food & beverage industry

 

The rise in a number of warehouses and growing end-user industries such as pharmaceutical, food & beverage, chemical, and textile industries is driving the growth of the plastic pallets market. According to the report, ‘Data & Trends, EU Food & Drink Industry 2018’, published by FoodDrinkEurope (a food industry confederation in the European Union) in October 2018, intra-EU exports of the Europe food & beverage industry accounted for US$ 303.77 Bn in 2017, and extra-EU exports accounted for US$ 122.40 Bn. The growing trade of food products & beverages is augmenting the growth of the plastic pallets market.

Key players include OMNIPAK S.R.O., ORBIS Corporation, Smart Flow Europe SA, Bekuplast Gmbh, Meridian Group D.O.O., CABKA Group, PURUS PLASTICS GmbH, Plastic Pallets Manufacturers, TBA Plastové Obaly S.R.O., and Paxxal Inc., among others

Europe is expected to hold a dominant position in the global plastic pallets market and this is accredited to the growing adoption of plastic pallets in the food & beverage industry. According to the report, ‘Data & Trends, EU Food & Drink Industry 2018’, published by FoodDrinkEurope (a food industry confederation in the European Union) in October 2018, the turnover of the food & drink industry in Europe was valued at US$ 1233.50 Bn in 2016, making the food & drink industry the highest revenue generating sector in the EU.

Plastic Pallets are normally used in shipping food and frozen goods and other pharmaceutical or medical products with very strict hygienic conditions. The food or the commodity is packed in a container which is then placed on the pallet. The pallet is covered with plastic sheets which help to keep the goods clean and protected. Plastic Pallets are durable and lightweight, which enables them to be easily shifted from one place to another.

Plastic Pallets can be used to ship all kinds of goods, ranging from perishable fruit to factory-produced medicines and medical devices. With the introduction of new technology and rising demands for efficient packaging solutions, plastic pallets have become much more durable, lightweight, portable, and cost-effective. Plastic Pallets are usually made from high-grade polyethylene, which makes them ideal for use in shipping and packaging applications.

Key Developments:

In March 2021, Dow announced that Yelopack, a technology-based supply chain comprehensive management company, has adopted AFFINITY™ polyolefin elastomer (POE) in its existing plastic pallets, which will increase the life span of its pallets by five years -- more than doubling their current life span.